Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Inovio Pharma (NQ: INO ) 5.550 -0.100 (-1.77%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Inovio Pharma < Previous 1 2 3 4 5 6 7 8 9 Next > Why Inovio Pharmaceuticals Is Plunging Today August 10, 2021 Solid business developments did not please investors. Via The Motley Fool Exposures COVID-19 Why Inovio's Stock Is Trading Lower Today August 10, 2021 Inovio Pharmaceuticals Inc (NASDAQ: INO) shares are trading lower by 9.9% at $8.65 after the company reported worse-than-expected second-quarter EPS and sales results.... Via Benzinga 54 Stocks Moving In Tuesday's Mid-Day Session August 10, 2021 Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) climbed 79.3% to $14.93 after the company announced positive interim results from the Phase 1 trial with FTX-6058 in healthy... Via Benzinga Analyzing Inovio Pharmaceuticals's Unusual Options Activity August 09, 2021 Inovio Pharmaceuticals (NASDAQ:INO) shares experienced unus... Via Benzinga The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight August 08, 2021 Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,... Via Benzinga Exposures Product Safety Inovio Pharmaceuticals (INO) Q2 2021 Earnings Call Transcript August 10, 2021 INO earnings call for the period ending June 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial Recap: Inovio Pharmaceuticals Q2 Earnings August 09, 2021 Shares of Inovio Pharmaceuticals (NASDAQ:INO) moved lower in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were down 95.00% year... Via Benzinga Why Inovio Stock Is Jumping Today August 09, 2021 Chinese regulators approved the initiation of two new clinical studies featuring Inovio's COVID-19 vaccine candidate, INO-4800. Via The Motley Fool Exposures COVID-19 What Does the Delta Variant Mean for Inovio Pharmaceuticals' Stock? August 05, 2021 Its vaccine candidate might be too far behind to matter. Via The Motley Fool Exposures COVID-19 Is Inovio Pharmaceuticals Primed For a Comeback? July 22, 2021 The past 12 months have been tough on the vaccine maker. Via The Motley Fool Exposures COVID-19 Here's Why Inovio Pharmaceuticals Soared 23% In June July 08, 2021 Encouraging news reversed what had been a steep sell-off for the clinical-stage biotech. Via The Motley Fool Exposures COVID-19 Earnings Scheduled For August 9, 2021 August 09, 2021 Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million. •... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For June 24, 2021 June 24, 2021 Upgrades Zelman upgraded the previous rating for Armstrong World Industries Inc (NYSE: Via Benzinga Inovio Pharmaceuticals: Return On Capital Employed Insights June 24, 2021 During Q1, Inovio Pharmaceuticals's (NASDAQ:INO) reported sales totaled $371.12 thousand. Despite a 79.13% in earnings, the company posted a loss of $52.55 million. In Q4, Inovio... Via Benzinga Inovio Pharmaceuticals Could See a Boost from Covid-19 Partnerships June 21, 2021 Some say INO stock could be the target of a short squeeze, but Inovio's Covid-19 vaccine program should be a sufficient reason to invest. Via InvestorPlace Exposures COVID-19 Should You Buy Biotech ETFs Now? June 16, 2021 Instead of trying to pick winners in this volatile space, it is better to invest in broader biotech ETFs that stand to benefit from increased investor interest and rising spending on drugs and... Via Talk Markets 12 Health Care Stocks Moving In Thursday's Intraday Session June 10, 2021 Gainers NuCana (NASDAQ:NCNA) shares moved upwards by 16.17% to $3.16 during Thursday's regular session. NuCana's stock is trading at a volume of 4.7 million shares... Via Benzinga Why Inovio Stock Is Sinking Today June 10, 2021 Investors appear to be taking some profits after yesterday's huge gain. Via The Motley Fool Exposures COVID-19 Twitter And Regeneron Lead The SPY In Another Mixed Day Of Trading June 09, 2021 U.S. indices at a mixed day of trading Wednesday as investors and traders weighed the U.S. 30-Year Treasury note falling to 2.1483%,... Via Benzinga Why Inovio Stock Looks Ready To Break Out, Make Bullish Reversal June 09, 2021 Inovio Pharmaceuticals Inc. (NASDAQ: INO) shares were trading higher Wednesday as retail traders continue to push high short interest stocks higher. The stock saw above average... Via Benzinga 62 Biggest Movers From Yesterday June 10, 2021 Gainers Aethlon Medical, Inc. (NASDAQ: AEMD) shares surged 388.2% to close at $10.79 on Wednesday in reaction to Zacks Article 'AEMD: First Ever In Vivo Removal Of COVID... Via Benzinga INO Stock: 2 Big Reasons Inovio Pharmaceuticals Is Shooting Higher Today June 09, 2021 Today, INO stock is soaring amid a recently announced expanded partnership for its Covid-19 vaccine and potential short squeeze implications. Via InvestorPlace Exposures COVID-19 12 Health Care Stocks Moving In Wednesday's Intraday Session June 09, 2021 Gainers Aethlon Medical (NASDAQ:AEMD) shares moved upwards by 347.96% to $9.9 during Wednesday's regular session. As of 12:30 EST, Aethlon Medical's stock is... Via Benzinga 48 Stocks Moving In Wednesday's Mid-Day Session June 09, 2021 Gainers Aethlon Medical, Inc. (NASDAQ: AEMD) shares jumped 371% to $10.41 in reaction to Zacks Article 'AEMD: First Ever In Vivo Removal Of COVID Virus From Bloodstream Of An... Via Benzinga Inovio Pharmaceuticals Insights: Return On Capital Employed June 08, 2021 During Q1, Inovio Pharmaceuticals's (NASDAQ:INO) reported sales totaled $371.12 thousand. Despite a 79.13% in earnings, the company posted a loss of $52.55 million. In Q4, Inovio... Via Benzinga Inovio, Advaccine to Share $100M in Cost for Late-Stage COVID-19 Vaccine Trial June 08, 2021 Inovio Pharmaceuticals Inc (NASDAQ: INO) has expanded its partnership with Advaccine Biopharmaceuticals Suzhou Co Ltd to jointly conduct a global... Via Benzinga Exposures COVID-19 These Vaccine Latecomers Could Still Win Big. Here's How June 07, 2021 The key is standing out from the crowd. Via The Motley Fool Topics Cannabis Exposures COVID-19 Cannabis Why Inovio Pharmaceuticals Stock Perked Up in May June 06, 2021 The biotech's pan-COVID-19 vaccine caught the eye of investors last month. Via The Motley Fool Exposures COVID-19 I Would Hope Inovio Isn’t Attracting ANY Serious Money June 03, 2021 It seems as though INO stock will have a tough time getting and staying in double digits Via InvestorPlace Is It Too Late to Buy Inovio Pharmaceuticals Stock? June 03, 2021 This troubled coronavirus vaccine developer has created far more woes than joys for investors. Via The Motley Fool Exposures COVID-19 < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.